Position
Chief Medical Officer
Company
Sagimet Biosciences Inc.
San MateoBiotechnologyHealth CarePharmaceuticalBiopharmaDescription
On April 20, 2026, Sagimet Biosciences announced the appointment of Andreas Grauer, M.D. as Chief Medical Officer, effective immediately. This follows the retirement of Eduardo Martins, M.D., who will continue to support the company as an external scientific advisor.
Quick answer
Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer (April 21, 2026). Sagimet Biosciences Inc. is based in San Mateo, California, United States.
- Who is the new Chief Medical Officer at Sagimet Biosciences Inc?
- Sagimet Biosciences Inc. named Andreas Grauer Chief Medical Officer, announced April 21, 2026.
- What did Sagimet Biosciences Inc. announce on April 21, 2026?
- On April 20, 2026, Sagimet Biosciences announced the appointment of Andreas Grauer, M.D. as Chief Medical Officer, effective immediately. This follows the retirement of Eduardo Martins, M.D., who will continue to support the company as an external scientific advisor.
- What does Sagimet Biosciences Inc. do?
- Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
- Where is Sagimet Biosciences Inc. based?
- Sagimet Biosciences Inc. is based in San Mateo, California, United States.
- Which similar companies made leadership changes around the same time?
- BridgeBio Oncology Therapeutics (April 22, 2026), NRx Pharmaceuticals (April 13, 2026), Abivax (April 12, 2026) and TORL BioTherapeutics (May 7, 2026) also announced leadership changes within 45 days of Sagimet Biosciences Inc.
Source: Fundz verified event record.
Other recent leadership changes in Pharmaceutical and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- BridgeBio Oncology Therapeutics Appoints Pedro J. Beltran as CEO and Idan Elmelech as COO (April 22, 2026)
- NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer (April 13, 2026)
- ABIVAX Appoints Michael Nesrallah as Chief Commercial Officer (April 12, 2026)
- TORL BioTherapeutics Appoints Aran Maree, M.D., as Chief Executive Officer (May 7, 2026)
- Minerva Neurosciences Appoints Dr. Sheila O’Connor as President and CEO (April 2, 2026)
- Vanda Pharmaceuticals Inc. Announces Resignation of Senior Executive (April 2, 2026)
Who to call at Sagimet Biosciences Inc., and when
A new leader at Sagimet Biosciences Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Sagimet Biosciences Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sagimet Biosciences Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sagimet Biosciences Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sagimet Biosciences Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sagimet Biosciences Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.